These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10751318)

  • 41. Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.
    Leblanc K; Sexton E; Parent S; Bélanger G; Déry MC; Boucher V; Asselin E
    Int J Oncol; 2007 Feb; 30(2):477-87. PubMed ID: 17203231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
    Wu J; Richer J; Horwitz KB; Hyder SM
    Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice.
    Singh M; Sétáló G; Guan X; Frail DE; Toran-Allerand CD
    J Neurosci; 2000 Mar; 20(5):1694-700. PubMed ID: 10684871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of blockers for the estrogen receptor (ER) and type 1 IGF-receptor on the levels of ER, ER mRNA and IGF-I mRNA in the rat uterus.
    Sahlin L; Eriksson H
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):359-65. PubMed ID: 8903419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.
    Kumar A; Klinge CM; Goldstein RE
    Int J Oncol; 2010 May; 36(5):1067-80. PubMed ID: 20372779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K; Thu N; Saville B; Safe S
    Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of estrogen receptor beta expression in Chinese hamster ovary (CHO) cells and comparison of estrogen-responsive gene transcription in cells adapted to serum-free media.
    Thomas PB; Risinger KE; Klinge CM
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):41-55. PubMed ID: 12943744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts.
    Rickard DJ; Waters KM; Ruesink TJ; Khosla S; Katzenellenbogen JA; Katzenellenbogen BS; Riggs BL; Spelsberg TC
    J Bone Miner Res; 2002 Apr; 17(4):580-92. PubMed ID: 11918216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
    Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
    Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting.
    Kelley KM; Rowan BG; Ratnam M
    Cancer Res; 2003 Jun; 63(11):2820-8. PubMed ID: 12782587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
    Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
    Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. cGMP-dependent ADP depolymerization of actin mediates estrogen increase in cervical epithelial permeability.
    Gorodeski GI
    Am J Physiol Cell Physiol; 2000 Dec; 279(6):C2028-36. PubMed ID: 11078720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Leeding KS; Hu XF; DeLuise M; Zalcberg JR; Bach LA
    Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
    Hall JM; Korach KS
    Mol Endocrinol; 2003 May; 17(5):792-803. PubMed ID: 12586845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contrasting effects of tamoxifen and ICI 182 780 on estrogen-induced calbindin-D 9k gene expression in the uterus and in primary culture of myometrial cells.
    Blin C; L'Horset F; Leclerc T; Lambert M; Colnot S; Thomasset M; Perret C
    J Steroid Biochem Mol Biol; 1995 Oct; 55(1):1-7. PubMed ID: 7577712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J; Kitlen JW; Briand P; Labrie F; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2003 Mar; 84(4):469-78. PubMed ID: 12732292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway.
    Wade CB; Robinson S; Shapiro RA; Dorsa DM
    Endocrinology; 2001 Jun; 142(6):2336-42. PubMed ID: 11356680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.